Literature DB >> 6347775

Drug treatment of hyperactivity in children.

K J Ottenbacher, H M Cooper.   

Abstract

Recently-developed quantitative reviewing procedures were applied to 61 selected studies in order to explore the efficacy of pharmacological management for children identified as hyperactive. Analysis of effect-size information derived from the studies revealed that the average child receiving drug treatment was less hyperactive than 88.5 per cent of the control children. 30 per cent of this effect could be attributed to placebo phenomenon. The analysis also indicated that drug therapy had the most pronounced effect on dependent variables consisting of standardized or informal measures of behaviour and the least effect on measures of IQ and academic achievement. The advantages of quantitative reviewing methodology for adding clarity and consensus to complex bodies of literature are demonstrated and discussed.

Entities:  

Mesh:

Year:  1983        PMID: 6347775     DOI: 10.1111/j.1469-8749.1983.tb13772.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  7 in total

Review 1.  Attention deficit hyperactivity disorder--a review.

Authors:  C Williams; B Wright; I Partridge
Journal:  Br J Gen Pract       Date:  1999-07       Impact factor: 5.386

Review 2.  Treatment of attention deficit hyperactivity disorder in children and adolescents: safety considerations.

Authors:  Mark L Wolraich; Laura McGuinn; Melissa Doffing
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

Review 3.  Understanding the effects of stimulant medications on cognition in individuals with attention-deficit hyperactivity disorder: a decade of progress.

Authors:  James Swanson; Ruben D Baler; Nora D Volkow
Journal:  Neuropsychopharmacology       Date:  2010-09-29       Impact factor: 7.853

4.  How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysis.

Authors:  H M Schachter; B Pham; J King; S Langford; D Moher
Journal:  CMAJ       Date:  2001-11-27       Impact factor: 8.262

5.  Efficacy and safety of Ritalin LA, a new, once daily, extended-release dosage form of methylphenidate, in children with attention deficit hyperactivity disorder.

Authors:  Joseph Biederman; Declan Quinn; Margaret Weiss; Sabri Markabi; Meredith Weidenman; Kathryn Edson; Goeril Karlsson; Harald Pohlmann; Sharon Wigal
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

Review 6.  Pharmacokinetic considerations in the treatment of attention-deficit hyperactivity disorder with methylphenidate.

Authors:  Mark L Wolraich; Melissa A Doffing
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

7.  Nonmedical use of prescription stimulants among college students: associations with attention-deficit-hyperactivity disorder and polydrug use.

Authors:  Amelia M Arria; Kimberly M Caldeira; Kevin E O'Grady; Kathryn B Vincent; Erin P Johnson; Eric D Wish
Journal:  Pharmacotherapy       Date:  2008-02       Impact factor: 4.705

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.